A previous study revealed that OXA exposure induces the expression of VEGF and VEGF receptors (VEGFR) in human colorectal cancer cells, explaining the benefits of anti-VEGF therapy in combination with chemotherapy for CRC patients100. Here, VEGFA is linked to colorectal carcinoma.